SARS-CoV-2 reinfection and implications for vaccine development

dc.contributor.author	Frediansyah, Andri
dc.date.accessioned	2021-03-31T09:21:08Z
dc.date.available	2021-03-31T09:21:08Z
dc.date.issued	2020
dc.identifier.issn	2164-554X
dc.identifier.uri	http://hdl.handle.net/10900/113834
dc.language.iso	en	en
dc.publisher	Taylor & Francis Inc	de_DE
dc.relation.uri	http://dx.doi.org/10.1080/21645515.2020.1830683
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	SARS-CoV-2 reinfection and implications for vaccine development	de_DE
dc.type	Article	de_DE
utue.quellen.id	20210304112512_00265
utue.publikation.seiten	3061-3073	de_DE
utue.personen.roh	Nainu, Firzan
utue.personen.roh	Abidin, Rufika Shari
utue.personen.roh	Bahar, Muh Akbar
utue.personen.roh	Frediansyah, Andri
utue.personen.roh	Emran, Talha Bin
utue.personen.roh	Rabaan, Ali A.
utue.personen.roh	Dhama, Kuldeep
utue.personen.roh	Harapan, Harapan
dcterms.isPartOf.ZSTitelID	Human Vaccines & Immunotherapeutics	de_DE
dcterms.isPartOf.ZS-Issue	12	de_DE
dcterms.isPartOf.ZS-Volume	16	de_DE
utue.fakultaet	07 Mathematisch-Naturwissenschaftliche Fakultät